LABORATORIO FARMAC.ERFO (RK7) — Cash Flow Quality Index
LABORATORIO FARMAC.ERFO (RK7) has a Cash Flow Quality Index of 2.20x as of December 2023. Operating cash flow of €1.30 Million exceeds net income of €590.33K, indicating high earnings quality where cash backs reported profits. Explore LABORATORIO FARMAC.ERFO debt service capacity to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
LABORATORIO FARMAC.ERFO Cash Flow Quality Index (2021–2023)
Historical Cash Flow Quality Index for LABORATORIO FARMAC.ERFO across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see RK7 operating cash flow.
Annual Cash Flow Quality Index for LABORATORIO FARMAC.ERFO (2021–2023)
Year-by-year earnings quality comparison for LABORATORIO FARMAC.ERFO.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 2.20x | €1.30 Million | €590.33K | ▲ +106.5% |
| 2022 | 1.06x | €761.80K | €716.07K | ▼ -45.8% |
| 2021 | 1.96x | €2.27 Million | €1.16 Million | — |